Pharmacovigilance, an arm of patient care with a charter to make the best use of medicines and data for the treatment or prevention of disease, is taking on growing importance in global public health. Pharmacovigilance is a multi and cross-area discipline that deals with incidence and frequency of adverse events of pharmaceuticals and medical devices worldwide. The reporting of adverse events is critical to the creation of a valid pharmacovigilance program that can identify adverse events before they have an impact on public health. However, language can be a barrier in the reporting process. In many instances, adverse events and databases are reported in the local language.